美因基因达成复牌指引 2月27日复牌

Core Viewpoint - The company, 美因基因 (06667), has met all resumption guidelines and has applied to resume trading of its shares on the Hong Kong Stock Exchange starting from February 27, 2026, at 9:00 AM [1] Group 1 - The company has successfully achieved compliance with all necessary resumption conditions [1] - The application for resumption of trading has been officially submitted [1]